e-Drug3D

289

ETHOSUXIMIDE


INN
ETHOSUXIMIDE

cas 77-67-8
CLASS

NERVOUS SYSTEM
ANTICONVULSANT
SUCCINIMIDES

ROUTE (list)

ORAL

ATC code

N03AD01
N03AD51

PK parameters

Tmax 5 HOUR
VD 45.5 LITER (65 KILOGRAM)
PPB 0 PERCENT
t1/2 60 HOUR

Target

TARGET VOLTAGE-DEPENDENT CHANNEL

DrugCentral

Voltage-dependent T-type calcium channel subunit alpha-1G UNIPROT O43497 CACNA1G

Download SDF file 3-ethyl-3-methylpyrrolidine-2,5-dione

Formula:
C7H11NO2

Calculated chemical properties:

MW 141.17
NB_atoms 10
XLogP 0.45
PSA 47.114
NB_HD 1
NB_HA 3
fsp3 0.71
Lipinski(0=no;1=yes) 1

FDA
NDA 012380 (label) INN (ETHOSUXIMIDE) ZARONTIN (PARKE DAVIS) APPROVAL= AP YEAR= 1960
NDA 080258 (label) INN (ETHOSUXIMIDE) ZARONTIN (PARKE-DAVIS) APPROVAL= AP YEAR= 1974
NDA 081306 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (TEVA PHARMS) APPROVAL= AP YEAR= 1993 DISCONTINUED
NDA 040253 (label) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (PHARM ASSOC) APPROVAL= AP YEAR= 2000
NDA 040430 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (BIONPHARMA) APPROVAL= AP YEAR= 2002
NDA 040506 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2003
NDA 040686 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (EPIC PHARMA LLC) APPROVAL= AP YEAR= 2008
NDA 200892 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (HERITAGE PHARMS INC) APPROVAL= AP YEAR= 2012
NDA 211928 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (ONESOURCE SPECIALTY) APPROVAL= AP YEAR= 2019
NDA 210654 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (PURACAP PHARM LLC) APPROVAL= AP YEAR= 2020

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL